RecruitingNCT05197764

Evaluation of Macroscopic Muscle Growth in Infants and Young Children With Spastic Cerebral Palsy

The Integration of Macroscopic and Microscopic Muscle Properties With Cell Modelling to Feature Altered Neuromuscular Behavior in Cerebral Palsy: 3D-Macroscopic Muscle Architecture in Cerebral Palsy


Sponsor

Universitaire Ziekenhuizen KU Leuven

Enrollment

229 participants

Start Date

Feb 11, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

A mixed longitudinal design study will be carried out to explore the onset and time course of morphological muscle changes on a macroscopic level in children with spastic cerebral palsy (SCP). Therefore, this project aims to (1) describe the macroscopic morphological muscle changes with increasing age and (2) evaluate the onset and development of muscle alterations in relation to the brain lesion (e.g., timing, extent and location), to the neuromuscular impairments and to treatment. Overall, this project will evaluate the macroscopic muscle properties by means of 3D freehand ultrasound (3DfUS).


Eligibility

Min Age: 6 MonthsMax Age: 9 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with acquired brain injury and spastic cerebral palsy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 6 Months to 9 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

UZ Leuven

Leuven, Vlaams-Brabant, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05197764


Related Trials